These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

506 related articles for article (PubMed ID: 30447221)

  • 1. The Biology and Application Areas of CRISPR Technologies.
    Adli M
    J Mol Biol; 2019 Jan; 431(1):1-2. PubMed ID: 30447221
    [No Abstract]   [Full Text] [Related]  

  • 2. Development and application of CRISPR/Cas9 technologies in genomic editing.
    Zhang C; Quan R; Wang J
    Hum Mol Genet; 2018 Aug; 27(R2):R79-R88. PubMed ID: 29659822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRISPR-Cas9 System: Opportunities and Concerns.
    Vasiliou SK; Diamandis EP; Church GM; Greely HT; Baylis F; Thompson C; Schmitt-Ulms G
    Clin Chem; 2016 Oct; 62(10):1304-11. PubMed ID: 27551006
    [No Abstract]   [Full Text] [Related]  

  • 4. The future of CRISPR technologies in agriculture.
    Gao C
    Nat Rev Mol Cell Biol; 2018 May; 19(5):275-276. PubMed ID: 29382940
    [No Abstract]   [Full Text] [Related]  

  • 5. Meeting Report: German Genetics Society-Genome Editing with CRISPR.
    Maier LK; Marchfelder A; Randau L
    Bioessays; 2020 Feb; 42(2):e1900223. PubMed ID: 31853989
    [No Abstract]   [Full Text] [Related]  

  • 6. Cas9 immunity creates challenges for CRISPR gene editing therapies.
    Crudele JM; Chamberlain JS
    Nat Commun; 2018 Aug; 9(1):3497. PubMed ID: 30158648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Foresight is 2020: Ten Bold Predictions for the New CRISPR Year.
    Barrangou R
    CRISPR J; 2019 Dec; 2(6):341-342. PubMed ID: 31860348
    [No Abstract]   [Full Text] [Related]  

  • 8. [CRISPR-Cas system as molecular scissors for gene therapy].
    Heinz GA; Mashreghi MF
    Z Rheumatol; 2017 Feb; 76(1):46-49. PubMed ID: 28124743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Toolkit of CRISPR-Based Genome Editing Systems in Drosophila.
    Xu J; Ren X; Sun J; Wang X; Qiao HH; Xu BW; Liu LP; Ni JQ
    J Genet Genomics; 2015 Apr; 42(4):141-9. PubMed ID: 25953352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted Base Editing Systems Are Available for Plants.
    Marzec M; Hensel G
    Trends Plant Sci; 2018 Nov; 23(11):955-957. PubMed ID: 30224156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A CRISPR-dCas Toolbox for Genetic Engineering and Synthetic Biology.
    Xu X; Qi LS
    J Mol Biol; 2019 Jan; 431(1):34-47. PubMed ID: 29958882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Refining CRISPR-based genome and epigenome editing off-targets.
    Luo Y
    Cell Biol Toxicol; 2019 Aug; 35(4):281-283. PubMed ID: 31227932
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of CRISPR/Cas Genome Editing Technology for Targeted Mutagenesis in Rice.
    Xu R; Wei P; Yang J
    Methods Mol Biol; 2017; 1498():33-40. PubMed ID: 27709567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Henceforth CRISPR.
    Nat Biomed Eng; 2020 Nov; 4(11):1023. PubMed ID: 33060800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radical Technology Meets Radical Application: An Interview with George Church.
    Davies K; Church GM
    CRISPR J; 2019 Dec; 2(6):346-351. PubMed ID: 31860351
    [No Abstract]   [Full Text] [Related]  

  • 16. And Then There Were Three: Discovering the Role of CRISPRs.
    Vergnaud G
    CRISPR J; 2019 Dec; 2(6):359-361. PubMed ID: 31860354
    [No Abstract]   [Full Text] [Related]  

  • 17. CRISPR-Cas9 for cancer therapy: Opportunities and challenges.
    Chen M; Mao A; Xu M; Weng Q; Mao J; Ji J
    Cancer Lett; 2019 Apr; 447():48-55. PubMed ID: 30684591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Advances in application of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated 9 system in stem cells research].
    Sun SJ; Huo JH; Geng ZJ; Sun XY; Fu XB
    Zhonghua Shao Shang Za Zhi; 2018 Apr; 34(4):253-256. PubMed ID: 29690746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of CRISPR/Cas9 gene-editing tools for developing models in drug discovery.
    Ahmad G; Amiji M
    Drug Discov Today; 2018 Mar; 23(3):519-533. PubMed ID: 29326075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Directed Evolution of CRISPR-Cas9 Base Editors.
    Winter J; Perez-Pinera P
    Trends Biotechnol; 2019 Nov; 37(11):1151-1153. PubMed ID: 31623959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.